Difference between revisions of "Liposarcoma"

Jump to navigation Jump to search
609 bytes added ,  03:15, 19 September 2014
(5 intermediate revisions by the same user not shown)
Line 35: Line 35:
*Most common malignant sarcoma in the retroperitoneum.
*Most common malignant sarcoma in the retroperitoneum.
*Not all (large) retroperitoneal adipocytic tumours are liposarcomas.
*Not all (large) retroperitoneal adipocytic tumours are liposarcomas.
*Prognosis - dependent on the location.
**Retroperitoneal: poor.
**Extremity: good - disease specific 5-year survival ~ 92%.<ref>{{Cite journal  | last1 = Lietman | first1 = SA. | last2 = Barsoum | first2 = WK. | last3 = Goldblum | first3 = JR. | last4 = Marks | first4 = KE. | last5 = Mascha | first5 = E. | last6 = Sundaram | first6 = M. | last7 = Muschler | first7 = G. | title = A 20-year retrospective review of surgically treated liposarcoma at the Cleveland Clinic. | journal = Orthopedics | volume = 30 | issue = 3 | pages = 227-34 | month = Mar | year = 2007 | doi =  | PMID = 17375550 }}</ref>


Notes:
Notes:
*Retroperitoneal sarcomas: #1: liposarcoma, #2: [[pleomorphic undifferentiated sarcoma]], #3: leiomyosarcoma, #4: [[MPNST]].
*Retroperitoneal sarcomas: #1: liposarcoma, #2: [[pleomorphic undifferentiated sarcoma]], #3: [[leiomyosarcoma]], #4: [[MPNST]].
**Extremely rare in retroperitoneum: [[synovial sarcoma]].
**Extremely rare in retroperitoneum: [[synovial sarcoma]].


48,436

edits

Navigation menu